Last updated: June 8, 2026

Back to directory

icometrix icobrain medical AI product profile

AI brain MRI software portfolio that quantifies and compares neurological imaging findings to support radiologist- and neurologist-reviewed care workflows.

Screenshot of the official icometrix icobrain product page
Medical imaging and radiology

Best fit

Programs that need standardized quantitative brain MRI reports for multiple sclerosis, dementia, ARIA, traumatic brain injury, epilepsy, Parkinson's disease, or brain tumor follow-up with specialist review.

Primary use case
FDA-cleared AI brain MRI quantification, longitudinal lesion and volume tracking, ARIA monitoring support, and disease-specific neurology imaging reports
Audience
Neurology practices, neuroradiology groups, MS centers, dementia and Alzheimer's programs, imaging centers, and health-system AI governance committees
Risk level
High
Pricing signal
Enterprise and clinical-program pricing is not public; request current module, geography, scan-volume, integration, security, and support terms.
Official sources
6 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating icometrix icobrain as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat icobrain as regulated medical image-processing software and match each deployment to the exact 510(k), software version, measured brain structures, disease module, intended user, region, and clinical workflow before using outputs in care decisions.
PrivacyReview DICOM pseudonymization, retained demographics, transfer encryption, remote icobridge access, cloud or local processing, support access, retention, audit logs, HIPAA/GDPR claims, ISO27001 scope, BAA or DPA terms, and re-identification controls.
EvidenceEvaluate icometrix publications and FDA summaries against the local scanner mix, MRI protocols, disease population, longitudinal interval, lesion and volume thresholds, ARIA workflow, false positives, false negatives, and specialist interpretation process.
WorkflowBest governed as quantitative MRI support for radiologists and neurologists, with explicit report-review responsibility, escalation rules for new activity or ARIA findings, treatment-decision boundaries, and post-deployment performance monitoring.

Where icometrix icobrain fits

icometrix describes icobrain as validated, FDA-cleared brain MRI AI software for comparing and quantifying neurological scans over time, with disease-specific reports across MS, dementia and Alzheimer's, ARIA, traumatic brain injury, epilepsy, Parkinson's disease, and brain tumors; FDA records list multiple icobrain 510(k) clearances for radiological image-processing software, while icobridge materials describe DICOM pseudonymization, TLS transfer, HIPAA/GDPR handling, and ISO27001 certification.

Not for: Standalone neurological diagnosis, replacing radiology interpretation, unsupported MRI protocols or disease modules, treatment decisions without clinician review, or assuming every icobrain report has identical FDA clearance.

What to verify before using icometrix icobrain

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products